Aurora Investment Counsel Haemonetics Corp Transaction History

Aurora Investment Counsel

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 23, 2022	SELL	$63.3 - $78.66 $594,576 - $738,853	-9,393 Reduced 29.86%	22,059 $1.63 Million
Q2 2022 Aug 12, 2022	SELL	$49.27 - $66.08 $3,596 - $4,823	-73 Reduced 0.23%	31,452 $1.99 Million
Q2 2022 Aug 12, 2022	BUY	$49.27 - $66.08 $3,596 - $4,823	73 Added 0.23%	31,525 $2.06 Million
Q1 2022 May 23, 2022	SELL	$43.77 - $63.22 $30,507 - $44,064	-697 Reduced 2.17%	31,452 $1.99 Million
Q4 2021 Feb 07, 2022	BUY	$49.55 - $74.59 $1.59 Million - $2.4 Million	32,149 New	32,149 $1.71 Million

332

53.8M

689K

345K

Ticker HAE
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 51,316,500
Market Cap $4.02B
Description
Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...

Get notified when there are updates to the investment portfolio of Aurora Investment Counsel, based on Form 13F filings with the SEC.

Stay updated on Aurora Investment Counsel with notifications on news.